Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Get Alerts JNJ Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: +2.9%
Join SI Premium – FREE
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9th, 2026. Management will participate in a Fireside Chat at 10:00 a.m. Eastern Time.
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48 hours after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511295368/en/
Media contact:
[email protected]
Investor contact:
[email protected]
Source: Johnson & Johnson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tanner Health and InStockRx Partner to Ensure Every Medication Dose Reaches a Patient in Need
- Solution Financial Reports Q2 2026 Financial Results
- Northern Cod and Capelin Quota Decisions Prioritize Short-term Gains Over Long-term Abundance
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share